VistaGen Therapeutics Inc... (VTGN)
NASDAQ: VTGN
· Real-Time Price · USD
3.31
0.35 (12.01%)
At close: Aug 15, 2025, 3:59 PM
3.32
0.27%
After-hours: Aug 15, 2025, 07:58 PM EDT
VistaGen Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
April - March.
| Fiscal Year | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 |
Net Income | -55.78M | -51.42M | -47.3M | -39.57M | -33.19M | -29.36M | -32.07M | -35.48M | -46.37M | -59.25M | -63.71M | -64.48M | -59.79M | -47.76M | -37.28M | -32.05M | -22.55M | -17.93M | -14.99M | -15.65M | -17.69M |
Depreciation & Amortization | 653K | 635K | 615.5K | 597.7K | 581K | 770K | 777.1K | 766.1K | 758.4K | 576.8K | 556.6K | 740.4K | 835K | 711.1K | 618K | 328.4K | 126.7K | 117.6K | 102.8K | 101.9K | 102.3K |
Stock-Based Compensation | 4.07M | 4.32M | 3.87M | 3.3M | 2.77M | 2.18M | 2.26M | 2.5M | 2.95M | 3.34M | 4.14M | 4.11M | 3.85M | 3.48M | 2.57M | 2.58M | 2.22M | 2.31M | 2.55M | 3.45M | 3.43M |
Other Working Capital | -2.52M | -1.2M | -804.9K | -601.1K | -219.7K | 271K | 417.5K | -144K | 1.76M | 2.96M | 2.65M | -413.3K | -1.92M | -2.07B | -2.07B | -2.06B | -2.06B | 437.88M | 437.37M | 437.01M | 433.9M |
Other Non-Cash Items | -492K | -389K | 1.21B | 1.21B | 1.21B | -196K | -1.21B | -1.21B | -1.2B | 10.7M | 9.56M | 7.19M | 3.66M | 2.97M | 722.2K | 182.7K | 4.16M | 3.49M | 2.79M | 3.98M | 207.2K |
Deferred Income Tax | n/a | n/a | -1.21B | -1.21B | -1.21B | n/a | 1.21B | 1.21B | 1.21B | -7.11M | -6.78M | -4.31M | -956.9K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 1.47M | 4.76M | 3.84M | 2.33M | 1.06M | 793K | -400K | -2.69M | -2.39M | 2.03M | 1.14M | -460.5K | 89.3K | -1.92M | -1.08M | 1.19M | 4.53M | 3.44M | 2.97M | 2.61M | -499.5K |
Operating Cash Flow | -50.07M | -42.1M | -39.23M | -33.49M | -28.79M | -25.81M | -26.09M | -31.49M | -41.64M | -49.72M | -57.83M | -59.94M | -55.05M | -45.26M | -34.95M | -27.89M | -15.44M | -12.07M | -9.37M | -8.66M | -13.8M |
Capital Expenditures | -46K | -88K | -28.7K | -61K | -103K | -61K | 179.7K | 199.5K | 175.1K | n/a | -212.1K | -199.5K | -225.6K | -200.4K | -225.8K | -377K | -425.3K | -275.4K | -249.9K | -98.8K | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | -528.3K | -528.3K | -528.3K | -528.3K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -28.28M | -24.98M | -21.07M | -18.65M | -5.42M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 20.03M | 12.03M | 7.5M | 5.5M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -103K | -103K | -103K | -103K | n/a | n/a | -212K | -212K | -212K | -175.31M | -375.5M | -375.5M | -375.5M | -350.3M | -425.2M | -425.2M | -425.3M | -275.4M | -98.8K | -98.8K | n/a |
Investing Cash Flow | -8.47M | -13.15M | -13.7M | -13.31M | -5.53M | -61K | -560.6K | -540.8K | -565.2K | -740.3K | -212.1K | -199.5K | -225.6K | -200.4K | -225.8K | -377K | -425.3K | -275.4K | -249.9K | -98.8K | n/a |
Debt Repayment | 930K | n/a | 1K | 500.00 | -784.1K | -985K | -986K | -1.3M | -820.2K | -721.5K | -721.7K | -411.6K | -104.3K | -3K | -3.7K | 160.6K | 46.5K | 221.1K | 221.2K | 185.4K | 212.5K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | -84.3K | -84.3K | -114.5K | -173.9K | -89.6K | -89.6K | -59.4K | n/a | -336.02M | -336.02M | -336.02M | -336.02M | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -583.3M | -583.3M | -583.3M | -945.1M | -1.41B | -1.41B | -1.41B | -1.39B | -1.3B | -1.3B | -1.3B |
Other Financial Acitivies | 201K | 201K | 201K | -120K | -204.3K | -204.3K | -602.5K | -387.5K | -386.7K | -335.1K | 63.1K | 2.08M | 5.41M | 368.11M | 1.42B | 1.51B | 1.51B | 1.49B | 1.4B | 1.3B | 1.3B |
Financial Cash Flow | 4.61M | 3.21M | 1.09M | 93.44M | 127.61M | 128.4M | 128.17M | 34.35M | -161.2K | -1.04M | -619.9K | 1.8M | 9.49M | 10.48M | 14.54M | 106.5M | 112.1M | 114.1M | 112.89M | 20.09M | 7.05M |
Net Cash Flow | -53.93M | -52.03M | -51.84M | 46.64M | 93.3M | 102.53M | 101.52M | 2.32M | -42.36M | -51.5M | -58.66M | -58.34M | -45.79M | -34.97M | -20.63M | 78.23M | 96.23M | 101.75M | 103.27M | 11.33M | -6.75M |
Free Cash Flow | -50.12M | -42.19M | -39.26M | -33.55M | -28.89M | -25.87M | -25.91M | -31.29M | -41.46M | -49.72M | -58.04M | -60.14M | -55.28M | -45.46M | -35.18M | -28.27M | -15.87M | -12.35M | -9.62M | -8.76M | -13.8M |